STAT3 was mostly involved in the activation of EMT, hormone Estrogen Receptor (ER), rat sarcoma/mitogen activated protien kinase RAS/MARK, and Receptor tyrosine kinase (RTK), while the major inactivated pathways were cell cycle and DNA damage response. This evidence concerns the gene MARK1 and sarcoma.